↓ Skip to main content

American Association for Cancer Research

Impact of APE1/Ref-1 Redox Inhibition on Pancreatic Tumor Growth

Overview of attention for article published in Molecular Cancer Therapeutics, September 2011
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (75th percentile)
  • Above-average Attention Score compared to outputs of the same age and source (60th percentile)

Mentioned by

patent
6 patents

Citations

dimensions_citation
94 Dimensions

Readers on

mendeley
73 Mendeley
Title
Impact of APE1/Ref-1 Redox Inhibition on Pancreatic Tumor Growth
Published in
Molecular Cancer Therapeutics, September 2011
DOI 10.1158/1535-7163.mct-11-0107
Pubmed ID
Authors

Melissa L. Fishel, Yanlin Jiang, N.V. Rajeshkumar, Glenda Scandura, Anthony L. Sinn, Ying He, Changyu Shen, David R. Jones, Karen E. Pollok, Mircea Ivan, Anirban Maitra, Mark R. Kelley

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 73 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 2 3%
Japan 1 1%
Unknown 70 96%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 12 16%
Student > Master 10 14%
Student > Bachelor 9 12%
Researcher 8 11%
Student > Postgraduate 5 7%
Other 17 23%
Unknown 12 16%
Readers by discipline Count As %
Agricultural and Biological Sciences 22 30%
Biochemistry, Genetics and Molecular Biology 16 22%
Medicine and Dentistry 8 11%
Pharmacology, Toxicology and Pharmaceutical Science 2 3%
Chemistry 2 3%
Other 8 11%
Unknown 15 21%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 6. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 02 November 2021.
All research outputs
#4,711,393
of 22,852,911 outputs
Outputs from Molecular Cancer Therapeutics
#893
of 3,863 outputs
Outputs of similar age
#26,116
of 125,993 outputs
Outputs of similar age from Molecular Cancer Therapeutics
#11
of 45 outputs
Altmetric has tracked 22,852,911 research outputs across all sources so far. Compared to these this one has done well and is in the 76th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,863 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.2. This one has gotten more attention than average, scoring higher than 67% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 125,993 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 75% of its contemporaries.
We're also able to compare this research output to 45 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 60% of its contemporaries.